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Glaucoma is the second leading cause of blindness in the 
world [1]. Therapeutic approaches used in clinical practice 
involve surgery or drugs designed to reduce the patient’s 
abnormally high intraocular pressure (IOP), the cardinal 
feature and risk factor of open-angle glaucoma. In theory, 
neuroprotective therapies designed to protect retinal ganglion 
cells (RGCs) from the damage induced by progressive and 
sustained increases in IOP could represent a third treatment 
strategy, but to date, no drug has demonstrated efficacy in 
clinical trials. Not surprisingly, given that the mechanisms 
of RGC injury in this neurodegenerative disease are likely to 
be multifactorial, act in a progressive fashion over protracted 
periods of time, and operate at the level of the soma and the 
axon, a single-drug therapeutic approach may never prove 
efficacious in practice.
In recent years, preclinical studies in the central nervous 
system (CNS) and other tissues have revealed that potent, 
endogenous mechanisms affording protection against acute 
injury can be induced by various mild preconditioning 
stressors [2-4]. The robust magnitude of protection in these 
animal models implies that the epigenetic response is mecha-
nistically pleiotropic, and involves gene expression changes in 
Molecular Vision 2013; 19:2360-2372 <http://www.molvis.org/molvis/v19/2360>
Received 31 May 2013 | Accepted 21 November 2013 | Published 23 November 2013
© 2013 Molecular Vision
2360
Role of hypoxia-inducible factor-1α in preconditioning-induced 
protection of retinal ganglion cells in glaucoma
Yanli Zhu,1 Lihong Zhang,1 Jeffrey M. Gidday1,2,3
1Department of Neurosurgery, Washington University School of Medicine St. Louis, MO; 2Department of Ophthalmology & Visual 
Sciences, Washington University School of Medicine St. Louis, MO; 3Department of and Cell Biology & Physiology, Washington 
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Purpose: We recently demonstrated in a mouse model of glaucoma that endogenous epigenetic mechanisms can be ac-
tivated by a repetitive hypoxic preconditioning (RHP) stimulus to provide robust retinal ganglion cell (RGC) protection. 
Although we also provided evidence that RHP prevents or delays the apoptotic demise of the RGC soma, the mechanisms 
responsible for signaling this epigenetic response, as well as the effectors of the glaucoma-tolerant phenotype at the 
somatic and axonal levels, remain unidentified. In the present study, we used conditional mutant mice lacking hypoxia-
inducible factor-1α (HIF-1α) in RGCs (HIF-1α RGC-knockout [KO] mice) to test the hypothesis that RHP-mediated 
activation of this transcription factor in these cells protects them from glaucomatous injury.
Methods: Adult HIF-1α RGC-KO mice, generated by mating floxed HIF-1α mice with math5-Cre mice, were used. 
Experimental glaucoma was induced unilaterally in the HIF-1α RGC-KO mice and matched wild-types by elevating 
the intraocular pressure to 16–20 mmHg for 3 consecutive weeks, secondary to episcleral vein ligation. Mice of each 
genotype were randomized to either an RHP protocol (six total exposures to systemic hypoxia [11% oxygen], interspersed 
over a 2-week period, completed 3 days before ligation surgery) or to an untreated group. RGC soma and axon injury was 
quantified with Neuronal Nuclei (NeuN) immunohistochemistry in retinal flat mounts and SMI32 immunohistochemistry 
in cross sections of the post-laminar optic nerve, respectively.
Results: HIF-1α RGC-KO mice exhibited normal retinal function and morphology, and crosses of math5-Cre mice with 
floxed ROSA26 reporter mice confirmed Cre recombinase activity was confined to the RGC axons and soma. Untreated 
wild-type mice exhibited a 30±2% loss of RGC soma and a 31±3% loss of RGC axons after 3 weeks of intraocular 
hypertension (both p<0.05 versus fellow eye). The 90% and 81% improvement in soma and axon survival, respectively, 
observed in the wild-type mice treated with RHP (both p<0.05 versus the glaucoma eye in the untreated mice) was still 
observed to a near identical extent in the RHP-treated HIF-1α RGC-KO mice. RHP had no effect on the magnitude 
of intraocular pressure elevation in either the KO or wild-type groups, indicating that protection was realized in both 
genotypes in the face of ongoing intraocular hypertension.
Conclusions: These findings indicate that the robust, glaucomatous protection of the RGC soma and axons induced by 
RHP does not require HIF-1α-mediated transcription of survival genes and other adaptive responses within the RGCs 
themselves. Rather, we infer that RGC survival is augmented secondary to the activation of other hypoxia-sensitive 
transcription factors in RGCs and/or the action of diffusible HIF-1α target gene proteins released from neighboring reti-
nal cells. Ideally, the involvement of such autocrine- and/or paracrine-based mechanisms would be confirmed in future 
studies, but distinct components of the integrated, pleiotropic, and multicellular basis of this endogenous epigenetic 
response may prove difficult to demonstrate experimentally, as we found in the present study.
Correspondence to: Jeffrey M. Gidday, Department of Neurosurgery, 
Box 8057, Washington University School of Medicine, 660 S. Euclid 
Ave., 5th Floor McMillan, St. Louis, MO 63110; Phone: (314) 286-
2795; FAX: (314) 286-2900; email: gidday@wustl.edu
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neuronal, glial, and vascular cells. In the retina, considerable 
evidence has accumulated supporting the ability of brief, 
hypoxic, or ischemic preconditioning stimuli applied before 
[5,6] and even after [7,8] an ischemic insult to transiently 
protect ganglion and other retinal cells. We demonstrated 
that the duration of the resultant ischemic tolerance in the 
retina could be extended from days to weeks by repeatedly 
presenting a hypoxic preconditioning stimulus [9]. That 
finding led us to test whether this sustained phenotypic 
change would also protect RGCs in the setting of glaucoma. 
Indeed, using an inducible mouse model of open-angle glau-
coma, we demonstrated significantly enhanced survival of 
the retinal ganglion cell (RGC) soma and axons with repeti-
tive hypoxic preconditioning (RHP) [10].
The present study was undertaken to begin to ascertain 
the mediators of this innate protective response. Because 
hypoxia was the triggering stimulus, we turned our atten-
tion to the potential involvement of the oxygen-dependent 
transcription factor known as hypoxia-inducible factor-1α 
(HIF-1α), a well-established “master regulator” of hypoxic 
adaptation and survival [11,12] that is expressed throughout 
the retina [13-15], including RGCs [16,17]. Considerable 
evidence supports the involvement of HIF-1α in hypoxic 
preconditioning-induced protection of the brain [18-20] 
and the retina [9-17,21] from ischemic injury. Moreover, we 
previously documented a unique retinal HIF-1α protein signa-
ture, in which the magnitude and duration of expression are 
increased in response to multiple versus single hypoxic chal-
lenges. This expression pattern provides correlative support 
for the hypothesis that the long-lasting protection against 
RGC glaucomatous injury induced by RHP [9] depends 
on HIF-1α. To obtain direct causal data for this hypothesis, 
we leveraged a Cre-Lox approach to generate mice lacking 
HIF-1α in the RGCs, and then assessed the effects of the 
gene deletion on RHP-mediated protection. Results of those 
studies are detailed herein.
METHODS
Animals and experimental groups: Conditional, retinal 
cell-specific HIF-1α knockout (KO) mice were generated by 
mating HIF-1αflox/flox mice on a SV129 background (graciously 
supplied by Dr. David C. Beebe at Washington University; 
originally from Dr. Randall S. Johnson at University of Cali-
fornia San Diego [22]) with math5-Cre+/? mice on a C57Bl/6J 
background (graciously supplied by Dr. Susan Culican at 
Washington University; originally from Dr. Russell Van 
Gelder [University of Washington]), which express at least 
one Cre recombinase allele under the control of the math5 
promoter. Math5 is a transcription factor intimately involved 
in directing differentiation of retinal cell progenitors into 
RGCs and other retinal neurons during development. The 
math5 lineage is essential for RGC competence, but math5 
progenitors also give rise to amacrine, horizontal, and photo-
receptor cells [23,24]. Thus, in the offspring of the resultant 
Cre-lox cross, HIF-1αflox/flox;math5-Cre double mutants (which 
we refer to as HIF-1α RGC-KO mice), HIF-1α is knocked 
out in all RGCs. Littermate HIF-1αflox/flox;Cre−/− mice were 
used as wild-type (WT) controls in all studies. The primer 
sequences for genotyping were as follows: 5′-GCA TTA CCG 
GTC GAT GCA ACG AGT GAT GAG-3′ (Cre-forward), 
5′-GAG TGA ACG-AAC CTG-GTC GAA ATC AGT GCG-3′ 
(Cre-reverse), 5′-ATA TGC TCT TAT GAA GGG-GCC TAT 
GGA GGC-3′ (for HIF-1α_flox5), and 5′-GAT CTT TCC 
GAG GAC CTG GAT TCA-ATT CCC-3′ (for HIF-1α_flox3).
To confirm the cell-specific expression and success of 
Cre recombinase in the Math5-Cre mice, we bred them to 
floxed ROSA26 reporter mice that express membrane bound 
tomato red fluorescence or green fluorescent protein (GFP) 
fluorescence before, or after, respectively, Cre recombinase-
mediated excision (Gt(ROSA)26Sortm4(ACTB-tdTomato,EGFP)Luo/J 
[stock #007576]; Jackson Labs, Bar Harbor, ME). Retinal flat 
mounts were prepared from the offspring and examined with 
confocal microscopy.
Mice were randomized, by genotype, into either an 
untreated glaucoma group or a glaucoma group with prior 
repetitive hypoxic preconditioning (RHP; see below); 
thus, a total of four experimental groups were studied. We 
intended to process the tissue to measure the RGC soma and 
post-laminar optic nerve axon integrity endpoints in both 
eyes of every animal in every group. However, occasion-
ally, technical problems precluded us obtaining one or the 
other endpoint. This resulted in the following groups/sizes: 
untreated WT mice (n=8 total, with n=6 for Neuronal Nuclei 
[NeuN], n=7 for SMI32, and n=5 for both), RHP-treated WT 
mice (n=11 total, with n=10 for NeuN, n=11 for SMI32, and 
n=10 for both), untreated HIF-1α RGC-KO mice (n=9 total, 
with n=7 for NeuN, n=7 for SMI32, and n=5 for both), and 
RHP-treated HIF-1α RGC-KO mice (n=7 total, with n=7 for 
NeuN, n=6 for SMI32, and n=6 for both).
Experimental glaucoma model and repetitive hypoxic 
preconditioning: All experimental methods and animal care 
procedures used were in accordance with National Insti-
tutes of Health and Association for Research in Vision and 
Ophthalmology guidelines for the care and use of laboratory 
animals, and approved by the Animal Studies Committee at 
Washington University. As described previously by our group 
[10,25], a sustained period of elevated IOP was induced by 
repeated ligation of the episcleral veins of one eye, allowing 
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the fellow eye of each animal to serve as a non-glaucomatous 
control. Briefly, the ketamine/xylazine-anesthetized mice 
received topical application of 0.5% proparacaine hydro-
chloride, and incising the conjunctiva and Tenon’s capsule 
exposed the episcleral veins, three of which over 300° of 
the limbus were doubly ligated with 11–0 nylon suture 
(Alcon Surgical, Fort Worth, TX), and then severed. Core 
body temperature was maintained at 37 °C in all animals 
throughout the surgical procedure via a thermoregulated 
heating pad. If IOP was not elevated at 24 h or did not remain 
elevated at the 1- or 2-week time points, additional ligations 
of one or more presumably patent veins were performed 
at these time points. There were no significant differences 
between the four experimental groups in the absolute number 
of ligations performed at any given follow-up time point (24 h 
to 3 weeks), or in the relative number of ligations performed, 
expressed as a proportion of the total number of animals in 
the group, at any given follow-up time point. Following the 
topical antibiotic, mice were recovered in their home cages 
during the 3-week period of experimental glaucoma. IOP 
determinations were made between 10 a.m. and 2 p.m. in 
both eyes before and at weekly intervals following the induc-
tion of unilateral intraocular hypertension using the TonoLab 
Rebound Tonometer system (Colonial Medical Supply, Fran-
conia, NH), as described previously by us [10,25] and others 
[26].
Before glaucoma was induced, animals of each geno-
type were randomized to RHP or normoxic control groups, 
as described previously [9,10]. Briefly, conscious mice were 
exposed for 2 h to a single period of systemic hypoxia (11% 
oxygen) three times per week (approximately every other day) 
for 2 consecutive weeks. The initial episcleral vein ligation 
surgery was then performed 3 days after the last hypoxic 
exposure.
Morphological and functional analyses of hypoxia-inducible 
factor-1α retinal ganglion cell-knockout mice: Morpho-
logical and functional endpoints in the HIF-1α RGC-KO 
mice were assessed to identify potential abnormalities from 
the CreLox-mediated loss of the HIF-1α gene in retinal cells 
expressing Math5. In one morphological analysis, the adult 
mice were euthanized, eyes were perfusion-fixed, embedded 
in paraffin, and 5-μm-thick serial sections were obtained and 
stained with hematoxylin and eosin to examine the retinal 
morphology. We also immunostained for HIF-1α in separate 
sections of the retinas from the adult mice of both genotypes, 
after we euthanized the animals during exposure to either 
normoxic room air or immediately after exposure to a single 
bout of hypoxia (2 h, 11% oxygen). After deparaffinization, 
rehydration, and antigen retrieval, nonspecific binding was 
blocked with prediluted 10% normal goat serum (S-1000, 
Vector Laboratories, Burlingame, CA) for 20 min at room 
temperature. Sections were then incubated overnight at 4 °C 
with primary antibodies (HIF-1α [#448SS, Lot#A, 1:100, 
Novus Biologicals, Littleton, CO] and brn3 [#SC6026, 1:25, 
Santa Cruz Biotechnology, Dallas, TX]), washed with PBS 
(Sigma-Aldrich, St. Louis, MO; 0.138 M NaCl, 0.0027 M 
KCl, pH 7.4), and then incubated with secondary antibodies 
(Alexa Fluor 488 donkey antirabbit immunoglobulin [IgG; 
#A21206, 1:200, Invitrogen, Grand Island, NY] and Alexa 
Fluor 594 donkey antigoat IgG [A11058, 1:200, Invitrogen], 
respectively) for 1 h at room temperature. Nuclei were coun-
terstained with 4’,6-diamidino-2-phenylindole dihydrochlo-
ride (#H-1200, Vector Laboratories). Slides were washed and 
mounted with fluorescence-preserving mounting medium. 
Negative control slides were run without each primary anti-
body to ascertain the background autofluorescence levels 
of the respective secondary antibodies. A BX60 Olympus 
microscope (Olympus, Center Valley, PA) and a Zeiss 
AxioCam digital (Zeiss, Göttingen, Germany) camera were 
used to capture images.
For assessments of retinal function, scotopic flash elec-
troretinograms were obtained simultaneously for both eyes 
of normothermic, adult WT, and HIF-1α RGC-KO mice, 
as described in detail in our previous studies [6,9]. Briefly, 
animals were dark-adapted overnight, anesthetized with 
chloral hydrate (350 mg/kg; Sigma-Aldrich) and xylazine 
(4 mg/kg; Burns Veterinary Supply, Inc., Rockville Center, 
NY), and the pupils were dilated with 1% tropicamide and 
2.5% phenylephrine, while the cornea was kept moist with 
1% carboxymethylcellulose. Signals generated from a 2-mm 
stainless steel loop electrode positioned on the corneal 
surface, relative to the reference electrode placed subcutane-
ously behind the ear and a ground electrode under the animal, 
in response to brief (10 µsec) white-light flashes (0.1 Hz) 
were amplified and digitized with dedicated hardware and 
software. The a-wave and b-wave amplitudes at a stimulus 
intensity of 0.88 log cd-s/m2 were then calculated for each eye 
by a blinded observer, to obtain a single a-wave and b-wave 
amplitude for each animal.
Quantification of retinal ganglion cell axonal integrity: 
As indices of RGC axon health and survival after 3 weeks 
of experimental glaucoma, axon integrity in the WT and 
HIF-1α RGC-KO mice was quantified in the post-laminar 
optic nerve (approximately 50–150 µm behind the globe) 
with confocal immunofluorescence microscopy of SMI32-
immunopositive axons, as described previously by us [10,25] 
and others [27-29]. Briefly, after the animals were euthanized 
by transcardial perfusion, optic nerve segments were fixed 
Molecular Vision 2013; 19:2360-2372 <http://www.molvis.org/molvis/v19/2360> © 2013 Molecular Vision 
2363
overnight in 4% paraformaldehyde, thrice rinsed with PBS, 
transferred to 10% formalin, and then paraffin-embedded. 
Four-µm-thick sections perpendicular to the long axis of 
the nerve were collected, deparaffinized, rehydrated, and 
subjected to antigen retrieval (a 10-min immersion in boiling 
antigen unmasking solution [H3300, Vector Laboratories]). 
After a 20-min incubation in blocking buffer, sections were 
incubated overnight at 4 °C with primary antibodies against 
the non-phosphorylated neurofilament heavy subunit SMI-32 
(1:1,000; mouse monoclonal; Covance, Emeryville, CA) 
and glial fibrillary acidic protein (1:200; rabbit polyclonal; 
G4546, Sigma), followed by room temperature incubation 
for 1 h with secondary antibody (1:400, goat antimouse 
IgG linked to Alexa Fluor 488, A11001, Molecular Probes 
(Grand Island, NY), for SMI-32; and 1;400, goat antirabbit 
IgG linked to Alexa Fluor 546, A11010, Molecular Probes, for 
glial fibrillary acidic protein). VectaShield Hardset Mounting 
Medium with 4’,6-diamidino-2-phenylindole dihydrochloride 
(H-1200, Vector Laboratories) was used for counterstaining 
nuclei. Confocal images (Carl Zeiss, LSM 5 PASCAL; 40X 
and 63X oil immersion objective [1.25 NA]) were obtained at 
excitation wavelengths of 405, 488, and 560 nm over an area 
of 146 µm × 146 µm. Total fluorescence intensities of SMI32-
positive axons within the nerve border were determined by 
binarizing the image after background subtraction to identify 
the total surface area in the nerve covered by SMI32 above 
the threshold, calculating the total fluorescence intensity of 
the resulting image, and then normalizing to the total area of 
SMI32-positive signal, as detailed previously [25].
Quantification of retinal ganglion cell soma survival: After 
3 weeks of sustained intraocular hypertension, the WT and 
HIF-1α RGC-KO mice in each group were euthanized, and 
the surviving RGC soma were quantified in retinal f lat 
mounts using NeuN immunohistochemistry, as described 
previously by us [25] and others [30-32]. Briefly, mice were 
euthanized by transcardial perfusion, and the retinas were 
harvested from each eye, washed three times in Tris-buffered 
saline with Tween-20 (TBST) buffer (50 mM Tris, 150 mM 
NaCl, and 0.05% Tween-20), and permeabilized for 30 min 
with 0.3% Triton X-100 (Sigma T-9284) in TBS buffer. 
After blocking nonspecific binding with 1% BSA (Jackson 
ImmunoResearch, West Grove, PA), 0.15% Triton X-100, 
and 10% normal goat serum (Jackson ImmunoResearch) 
in TBST for 30 min at room temperature, the retinas were 
incubated overnight at 4 °C with NeuN (1:500; monoclonal 
anti-NeuN; MAB377, Chemicon/Millipore, Billerica, MA). 
Secondary antibody (1:400; goat antimouse IgG linked to 
Alexa Fluor 568, A11004, Invitrogen) was applied for 1 h at 
room temperature following a TBST wash, and the retinas 
were then flat-mounted with 50% glycerol (G-5516, Sigma) 
and coverslipped.
Eight distinct 221,600 μm2 (460 µm × 460 µm) regions 
of the peripheral retina (two per quadrant) were examined 
with confocal fluorescence microscopy (Carl Zeiss, LSM 5 
PASCAL; 20X objective; 0.5 NA; excitation wavelength=560 
nm). A blinded observer initially established fluorescence 
thresholds for each experimental/fellow eye pair and applied 
manual corrections of scanned images to remove signal 
artifacts; thereafter, AnalySIS software (Soft Image System 
GmbH, Munster, Germany) was used to automatically count 
the NeuN-positive RGC soma, which included all homoge-
neously stained and round NeuN-positive cell bodies.
Statistical analysis: Results are provided as means±standard 
error of the mean (SEM). Nonparametric signed-rank and 
rank-sum tests were used to identify significant differences 
between measures from paired eyes in the same animal and 
from eyes in different animal groups, respectively. Differ-
ences in IOP within and between animals in the four experi-
mental groups over the 3-week period of intraocular hyper-
tension, as well as differences in the number of episcleral vein 
ligations performed between the four experimental groups, 
were identified with one-way repeated measures ANOVA. In 
all instances, p<0.05 was accepted as significant.
RESULTS
Characterization of the hypoxia-inducible factor-1α retinal 
ganglion cell-knockout mice: Several measurements were 
undertaken in the HIF-1α RGC-KO mice to confirm normal 
morphology and function, as well as to characterize the cell 
specificity and efficiency of the HIF-1α knockdown. First, 
we crossed math5-Cre mice with a line of floxed ROSA26 
reporter mice that endogenously express a tomato red 
fluorescent protein in the membrane of all cells. Because 
they also incorporate a GFP reporter in this locus with an 
upstream loxP-flanked stop cassette, membranes fluoresce 
green following Cre-mediated recombination in the resulting 
double mutant offspring, if the cells express math5-Cre. As 
can be seen in Figure 1, RGC axons coursing through the 
nerve fiber layer of the mid-peripheral and central retina are 
brightly fluorescent, but not retinal blood vessels, indicative 
of a functional Cre transgene, and consistent with its localiza-
tion to all RGCs. A similar expression pattern was observed 
in the peripheral retina (data not shown). The fluorescent cell 
membranes of some underlying soma are also evident in the 
photomicrograph, implicating them as Cre-expressing RGCs. 
No GFP fluorescence was observed anywhere in the retina in 
F1 offspring from Cre-negative mice crossed with ROSA26 
reporter mice (data not shown).
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As shown in Figure 2, HIF-1α immunohistochemistry on 
retinal cross sections in WT mice revealed HIF-1α-positive 
cells throughout the retinas even under normoxic control 
conditions, including cells in the ganglion cell and inner 
nuclear layers, as well as in photoreceptors (although much 
of the signal in the photoreceptor layer was the result of 
antibody autofluorescence; data not shown). In response to 
hypoxia, HIF-1α-positive expression was greatly enhanced 
throughout the tissue. Coimmunostaining for the RGC-
specific antigen brn3 revealed both HIF-1α-positive and 
brn3-positive cells in the ganglion cell layer, indicative of 
RGCs, as well as HIF-1α-positive and brn3-negative cells, 
indicative of either displaced amacrine cells or brn3-negative 
RGCs. In the HIF-1α RGC-KO mice, a similar baseline and 
hypoxia-driven increase in HIF-1α expression was evident 
throughout the retina, including within the ganglion cell 
layer. However, upon closer examination, it was clear that, 
although HIF-1α-positive cells could be identified in this 
layer, no brn3-positive cells coimmunostained for HIF-1α in 
sections from either normoxic or hypoxic mice, implicating 
the former as displaced amacrine cells. These results confirm 
that brn3-positive RGCs in the HIF-1α RGC-KO mice lacked 
HIF-1α protein expression, but we cannot say with certainty 
from these specific results that all RGCs lacked the HIF-1α 
protein.
The hematoxylin and eosin−stained retinas from the 
adult HIF-1α RGC-KO mice looked unremarkable and essen-
tially identical to those from WT mice. As shown in the repre-
sentative cross sections (Figure 3), the relative cell densities 
in the different retinal layers and the relative thicknesses of 
the different retinal layers were similar from the peripheral to 
the central retina in each genotype, suggesting normal devel-
opment of the retina in the HIF-1α RGC-KO mutants. Func-
tionally, we observed normal a-wave and b-wave amplitudes 
in the resting scotopic flash electroretinograms measured in 
adult HIF-1α RGC-KO mice that were indistinguishable from 
those recorded in the WT mice (Figure 4).
Figure 1. Math5-Cre reporter mice. 
Confocal fluorescence microscopy 
image of a retinal flat mount from 
an animal derived from crossing 
ROSA26 green fluorescent protein-
reporter mice with math5-Cre mice. 
Note the presence of green fluores-
cence protein (GFP) in the retinal 
ganglion cell axons and some 
underlying soma in the ganglion 
cell layer, reflecting the presence 
of math5-Cre in these cells, but the 
lack of math5-Cre expression in 
retinal vascular cells (red). Scale 
bar=100 µm.
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Figure 2. Hypoxia-inducible factor-1α (HIF-1α) immunohistochemistry in normoxic and hypoxic wild-type and HIF-1α retinal ganglion 
cell-knockout mice. HIF-1α expression is shown in representative wild-type (WT; A, B) and HIF-1α retinal ganglion cell-knockout (RGC-
KO) mice (C, D) under normoxic (A, C) and hypoxic (B, D) conditions. The HIF-1α (green), brn3 (red), 4’,6-diamidino-2-phenylindole 
dihydrochloride (DAPI; blue), and “merged” images are shown in each row, left to right. In the images from the WT mice (A, B), arrowheads 
identify examples of HIF-1α and brn3 copositive RGCs in the ganglion cell layer (inset in the merged image shows one example at higher 
magnification), and arrows identify HIF-1α-positive but brn3-negative amacrine cells (or brn3-negative RGCs) in the ganglion cell layer. In 
the images from the HIF-1α RGC-KO mice (C, D), arrowheads identify examples of HIF-1α-negative but brn3-positive RGCs in the ganglion 
cell layer (inset in the merged image shows one example at higher magnification), and arrows identify HIF-1α-positive but brn3-negative 
amacrine cells in the ganglion cell layer. Scale bar=20 µm.
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Intraocular pressure: As shown previously by our group 
[10,25], our episcleral vein ligation protocol resulted in consis-
tent and sustained elevations in IOP in all four experimental 
groups, starting 24 h after the initial surgery and lasting 
for 3 weeks (when all endpoints were measured; Figure 5). 
Baseline IOP values did not differ between the eyes in any 
given group, or between groups; baseline IOPs ranged from 
9.8±0.6 to 10.8±0.9 mmHg in fellow eyes, and from 10.4±0.5 
to 12.0±0.6 mmHg in experimental eyes. The increases in 
IOP measured in the experimental eyes at all four time points 
were significantly greater (p<0.001 to p=0.039) at each time 
point than the respective baseline IOP value for that eye, and 
significantly greater (p<0.001 to p=0.016) than the respec-
tive IOP in the corresponding fellow eye at the same time 
point. IOPs in the experimental group ranged from 16.5±1.4 to 
16.8±1.5 mmHg at 24 h, from 19.0±1.5 to 20.0±2.0 mmHg at 1 
week, from 17.0±0.7 to 19.0±1.0 mmHg at 2 weeks, and from 
15.9±1.1 to 19.3±0.9 mmHg at 3 weeks of intraocular hyper-
tension. There were no statistically significant differences in 
the extent of IOP elevation in the experimental eyes among 
the four groups at any time point. In sum, the experimental 
eyes in our study started with the same IOPs, and experienced 
the same elevation in IOP, independent of genotype or prior 
RHP treatment.
Retinal ganglion cell soma protection by repetitive hypoxic 
preconditioning in wild-type and hypoxia-inducible factor-1α 
retinal ganglion cell-knockout mice: As shown in Figure 6, 
consistent with what we reported previously in other mouse 
strains [10,25], 3 weeks of experimental glaucoma led to 
Figure 3. Hematoxylin and eosin–
stained cross sections of retinas 
from wild-type and hypoxia-
inducible factor-1α retinal ganglion 
cell-knockout mice. No gross 
differences in cell body densities 
or layer thicknesses were noted 
between the two genotypes across 
the retina, as exemplified by these 
two representative images (n=3 
each) from the mid-central retina 
from the wild-type (WT; left) and 
hypoxia-inducible factor-1α retinal 
ganglion cell-knockout (HIF-1α 
RGC-KO; right) mice. Scale bar=50 
µm. 
Figure 4. Flash electroretinogram wave amplitudes in wild-type and 
hypoxia-inducible factor-1α retinal ganglion cell-knockout mice. 
Amplitudes of a-waves (filled bars) and b-waves (shaded bars) of 
resting scotopic flash electroretinograms measured in wild-type 
(WT; left; n=8) and hypoxia-inducible factor-1α retinal ganglion 
cell-knockout (HIF-1α RGC-KO; right; n=8) mice are shown. 
Means±standard error of the mean (SEM). 
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significant RGC soma loss in the WT mice; specifically, 
30±2% (p=0.016; n=7) of NeuN-positive soma were lost in 
non-preconditioned animals, relative to respective fellow 
eyes. RHP completely prevented (p<0.001) RGC soma loss 
in the WT mice (n=7), with 97±3% of NeuN-positive cells 
still remaining (not significantly different [p=0.375] from 
fellow eyes), a robust protective effect in line with what we 
reported earlier for RHP, using brn3 as an RGC immunolabel 
[10]. Loss of NeuN-positive cells in response to 3 weeks of 
intraocular hypertension was similar (p=0.445) in the non-
preconditioned HIF-1α RGC-KO mice (28±7% of NeuN-
positive cells lost; n=6; p=0.031) and the non-preconditioned 
WT mice. However, RHP also protected the RGC soma in the 
HIF-1α RGC-KO mice (n=10) significantly (p=0.004), with 
93±9% of the NeuN-positive soma surviving (not signifi-
cantly different from fellow eyes [p=0.164]; Figure 6). Thus, 
HIF-1α RGC-KO mice, despite lacking the HIF-1a gene in 
RGCs, were still protected from glaucoma-induced RGC 
soma loss by our RHP stimulus.
Retinal ganglion cell axon protection by repetitive hypoxic 
preconditioning in wild-type and hypoxia-inducible factor-1α 
retinal ganglion cell-knockout mice: In line with our previous 
studies of experimental glaucoma [10,25], Figure 7 illustrates 
that sustained elevations in IOP for 3 weeks in the WT mice 
resulted in a significant loss of axons at the post-laminar 
optic nerve level that was robustly and significantly attenu-
ated with RHP. Specifically, a 31±3% reduction (p=0.016) 
in SMI32 fluorescence intensity was recorded in the non-
preconditioned WT mice (n=7), but in the RHP-treated mice 
(n=6), this loss was significantly (p=0.001) abrogated, with 
94±2% of the SMI32-positive axons remaining, not signifi-
cantly different (p=0.219) from fellow eyes. Importantly, as 
observed for the RGC soma, RHP also protected the HIF-1α 
RGC-KO mice against glaucomatous RGC axon loss. In 
particular, the non-preconditioned HIF-1α RGC-KO mice 
(n=7) exhibited a 23±3% loss (p=0.016 versus fellow eyes) in 
SMI32 fluorescence intensity after 3 weeks of experimental 
glaucoma, whereas 95±2% of the SMI32-positive axons 
remained in the RHP-treated HIF-1α RGC-KO mice (n=11; 
p=0.001 versus non-preconditioned HIF-1α RGC-KO mice). 
Both responses closely paralleled those measured in the WT 
mice. Thus, RHP protected RGC axons from glaucomatous 
injury despite the Cre-Lox-mediated deletion of the HIF-1a 
gene in RGCs.
DISCUSSION
Results of the present study in RGC-specific, conditional 
HIF-1α-null mice indicate that the endogenous epigenetic 
mechanisms induced by RHP, which we showed previously 
provided RGCs somatic and axonal protection against glau-
comatous injury [10], do not depend on autocrine-based, 
HIF-1α-mediated transcriptional activation within RGCs 
themselves. Given the robustness of the protection induced 
by RHP against glaucomatous [10] and ischemic [9] injury, 
it is not unlikely that RHP promotes a pleiotropic epigenetic 
response that is not only operative at the somatic and axonal 
levels of the cell but also mechanistically redundant—all 
Figure 5. Intraocular pressure in wild-type and hypoxia-inducible 
factor-1α retinal ganglion cell-knockout mice with and without 
repetitive hypoxic preconditioning. Intraocular pressure (IOP) in the 
experimental eyes (filled symbols) and respective fellow eyes (open 
symbols) in the wild-type (WT; red; n=10) and hypoxia-inducible 
factor-1α retinal ganglion cell-knockout (HIF-1α RGC-KO; purple; 
n=8) groups without repetitive hypoxic preconditioning (RHP), 
and the WT (green; n=8) and HIF-1α RGC-KO (blue; n=14) with 
prior RHP over the 3-week period of intraocular hypertension are 
shown. All IOP values for the experimental eyes in each group at 
24 h and 1, 2, and 3 weeks were significantly different from their 
respective baselines and from their fellow eyes at each time point, 
but no statistically significant differences were noted among the 
four groups. Mean±standard error of the mean (SEM). 
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Figure 6. Retinal ganglion cell 
soma protection in wild-type and 
hypoxia-inducible factor-1α retinal 
ganglion cell-knockout mice with 
experimental glaucoma by prior 
repetitive hypoxic preconditioning. 
Quantification of NeuN–positive 
soma in the retinal ganglion cell 
layer following 3 weeks of intra-
ocular hypertension in the four 
experimental groups, normalized to 
fellow eyes (black bars) are shown. 
Note that repetitive hypoxic precon-
ditioning (RHP) provided protec-
tion against the glaucomatous loss 
of the retinal ganglion cell (RGC) 
soma in wild-type (WT; green) and 
hypoxia-inducible factor-1α retinal 
ganglion cell-knockout (HIF-1α 
RGC-KO; blue) mice. *p<0.05 versus fellow eye; #p<0.05 versus non-preconditioned glaucoma in the same genotype. Means±standard 
error of the mean (SEM). 
Figure 7. Retinal ganglion cell 
axon protection in wild-type and 
hypoxia-inducible factor-1α retinal 
ganglion cell-knockout mice with 
experimental glaucoma by prior 
repetitive hypoxic preconditioning. 
Quantification of SMI32-positive 
axons in the post-laminar optic 
nerve following 3 weeks of intra-
ocular hypertension in the four 
experimental groups is shown, 
normalized to fellow eyes (black 
bars). Note that repetitive hypoxic 
preconditioning (RHP) provided 
protection against the glaucoma-
tous loss of retinal ganglion cell 
(RGC) axons in the wild-type 
(WT; green) and hypoxia-induc-
ible factor-1α retinal ganglion 
cell-knockout (HIF-1α RGC-KO; blue) mice. *p<0.05 versus fellow eye; #p<0.05 versus non-preconditioned glaucoma in the same genotype. 
Means±standard error of the mean (SEM). 
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of which may have contributed to the lack of phenotype we 
observed in the HIF-1α RGC-KO mice.
That HIF-1α is a canonical transcriptional regulator of 
survival-enhancing genes throughout the body is well estab-
lished [11,12,18,33]. Considerable physiologic [9,17,34] and 
pharmacologic [13,21,35,36] evidence exists showing that 
prior augmentation of HIF-1α expression reduces pathology 
in models of retinal ischemia [9,17,21,35], oxygen-induced 
retinopathy [13], and phototoxicity [34,36]. Moreover, there 
is ample evidence that hypoxia drives HIF-1α expression in 
the retina in general [14,15] and in RGCs in particular [16,17]. 
In fact, in an earlier study [9], we documented distinct, time-
dependent changes in retinal HIF-1α expression in response 
to a single bout of systemic hypoxia versus the multiple expo-
sures to hypoxia that defined the RHP stimulus we used in the 
present investigation. Nevertheless, this uniquely protracted 
expression pattern, while consistent with the long-lasting 
cytoprotective phenotype exhibited by RGCs in RHP-treated 
mice subjected to ischemia [9] or glaucoma [10], provides 
only correlative evidence for HIF-1α’s participation in the 
observed protection. Thus, we pursued this causal study, 
leveraging RGC-specific HIF-1α knockout mice to test our 
hypothesis that this transcription factor would be a critical 
mediator of a repetitive hypoxia-induced, glaucomatous 
injury-resistant RGC phenotype [10].
Several investigators, including many in the field of 
retinal neurodegeneration [37], have leveraged Cre-Lox 
genetics to create mice that allow the documentation of 
causality regarding the injury or protection mechanisms 
operative in a given retinal cell type. To knock out HIF-1α 
selectively in RGCs, we mated floxed HIF-1α mice to Math5-
Cre mice. Math5 is a transcription factor that determines RGC 
competence during RGC differentiation [23,38], and thus 
is present in every RGC, as well as in some horizontal and 
amacrine cells and some photoreceptors [24]. Thus, all RGCs 
in the retinas of the resulting progeny should lack HIF-1α. To 
validate this, we also crossed Math5-Cre mice with Rosa26 
reporter mice in which a membrane-targeted, red fluores-
cent protein is floxed; Cre-mediated recombination results 
in a green fluorescent product, which we observed in flat-
mounted retinas as uniformly distributed in the RGC axons 
and underlying soma (Figure 1), consistent with the expected 
RGC localization of a functional Math5-Cre. Using histology 
(Figure 3) and scotopic electroretinography (Figure 4), we 
validated that the HIF-1α RGC-KO mice used in our studies 
exhibited no structural or functional abnormalities. Finally, 
we obtained immunohistochemical evidence in our HIF-1α 
RGC-KO mice that HIF-1α protein expression in RGCs is 
lacking under baseline and hypoxic conditions (Figure 2). 
This series of successful validation measures supported our 
intended use of these mice to test the hypothesis that RGC 
HIF-1α contributes to the enhanced survival of these cells in 
our glaucoma tolerance model [10]. That said, an important 
caveat of our study is that we did not provide quantitative data 
that would more clearly document the efficiency of the Cre-
mediated excision of the HIF-1α gene in RGCs; our results 
from reporter mice and from our immunohistochemical 
analyses only qualitatively address this concern.
Overall, we found that RHP still promoted protection of 
the RGC soma and axons in HIF-1α RGC-KO mice, to levels 
as robust as that seen in their wild-type counterparts, indi-
cating that the transcriptional activity of HIF-1α within RGCs 
is not required for the ability of RHP to protect either the 
soma or the axons of these cells from glaucomatous injury. 
However, our results do not provide evidence for alternative 
explanations for how the RGC-protective phenotype is real-
ized independent of HIF-1α. One possibility is that HIF-1α-
derived cytoprotective mediators, such as erythropoietin, 
heme oxygenase-1, VEGF, and adrenomedullin, and the 
protein products of many other prosurvival genes whose tran-
scription is activated by HIF-1α are produced and released 
into the extracellular space by neighboring retinal cells and 
then act through their respective receptors on the RGCs to 
exert protection. How such a diffusible mediator within 
the retina protects the more distant RGC axon, the demise 
of which is thought to occur by mechanisms distinct from 
the RGC soma [39,40], represents an additional unknown. 
Another possibility is that, since hypoxia can drive changes in 
gene expression through other hypoxia-sensitive transcription 
factors (e.g., nuclear factor (erythroid-derived 2)-like 2 [Nrf-
2], nuclear factor kappa B [NFĸB], tumor protein 53 [p53], 
signal transducer and activator of transcription 3 [STAT-3], 
activator protein 1 [AP-1]) [41,42], RGC resistance to glauco-
matous injury may be realized in an autocrine or paracrine 
manner through these HIF-1α-independent transcriptional 
mechanisms. Finally, the repetitive hypoxic stimulus may 
induce in RGCs, or other neighboring retinal or vascular 
cells, the hypoxia-responsive isoform HIF-2α; functional 
roles for this transcription factor and its gene products have 
already been described in this tissue [43-46]. Further studies 
are needed to identify and confirm the involvement of these 
epigenetic modulators. More than likely, the robust protec-
tion afforded by RHP is mechanistically multifactorial, and 
represents an integrated, multicellular response designed to 
ensure the viability of the entire tissue.
Results of the present investigation indicate that the 
complex mechanisms of innate retinal neuroprotection 
may not easily be revealed by the deletion of a single gene 
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in a single retinal cell type. In fact, in a similarly designed 
study, the cell-specific, Cre-mediated deletion of HIF-1α in 
photoreceptors also was without effect on the photoreceptor-
protective response induced by hypoxic preconditioning 
[34]. Similarly, Müller cell-specific knockdown of the 
interleukin-6 receptor gp130 did not negatively influence 
the ability of cyclic light to precondition against subsequent 
phototoxicity [47]. Taken together, our findings and the 
results of these studies suggest two, potentially inclusive, 
possibilities for the RHP-mediated protection of RGCs: 
(1) Survival factors released by neighboring cells, whether 
neuronal or glial or endothelial, subserve a mechanism that 
helps ensure pan-retinal protection, and/or (2) multiple, func-
tionally redundant stress-responsive signaling pathways exist 
in retinal cells, with HIF-1α-mediated transcription being just 
one, that increase the likelihood that an adaptive, epigen-
etic responses of the cell will be realized. That the retinal 
messenger RNA levels of several other HIF-1α-independent 
prosurvival genes known to be induced by hypoxia were not 
affected by photoreceptor-specific HIF-1α gene knockdown 
[48] supports the former hypothesis; however, the list of 
potential cytoprotective mediators is likely to be much longer 
than those measured.
In summary, the in vivo glaucomatous protection 
provided the RGC soma and axons of wild-type mice by 
RHP [10] persists even in mutant mice lacking the HIF-1α 
gene in their RGCs. This implies an epigenetic response to 
the RHP stimulus by RGCs that is HIF-1α-independent or a 
paracrine-based mechanism of RGC protection secondary to 
RHP-stimulated HIF-1α gene target protein elaboration and 
release from neighboring retinal cells. In fact, neither of these 
possibilities is mutually exclusive. Our findings are consistent 
with an endogenous, multicellular, pleiotropic mechanism 
of RGC protection that may not be revealed by deletion of 
a single gene in a specific retinal cell type. Translationally 
speaking, the quest to pharmacologically induce such a 
protective response in glaucoma patients may require multiple 
drugs to coordinately activate the many signaling pathways 
regulating a broad set of cell-specific epigenetic responses. 
Attempts to administer any number of the many different 
effector proteins in an effort to mimic the glaucoma-tolerant 
phenotype may also present an insurmountable challenge. 
Thus, ultimately, exposing patients to a physiologic stimulus, 
such as intermittent hypoxia, may be the most efficacious 
therapeutic approach.
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